ARAdi Rotem

Adi Rotem

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adi Rotem has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    GMP-Cor: Quantifying Transcriptional Dysregulation in Antibiotic Tolerance and Persistence

    by Alon Gutfreund, Adi Rotem, Irine Ronin, Adam Z. Rosenthal, Oded Agam, Nathalie Q. Balaban

    When cells are exposed to stress, they typically activate stress-response pathways and enter a regulated growth-arrest. But what if the stress overwhelms these pathways? In such cases, cells may enter a disrupted growth-arrest - a poorly adapted, abrupt cessation of growth, characterized by a broad distribution of lag times upon stress removal [1]. This distribution underlies antibiotic persistence during stress recovery[2]. Therefore, gaining a deeper understanding of the disrupted growth-arrest is important for developing more effective antibiotic therapies. In this study, we perform single cell RNA-seq on bacteria in disrupted conditions. We develop GMP-Cor: a metric to quantify dysregulation and analyze gene-gene correlation patterns in sparse single-cell data. We find that gene-gene correlations are significantly reduced in disrupted cells compared to regulated cells, providing direct evidence that this tolerance-enhanced state, along with its increased membrane sensitivity, is associated with global-dysregulation. We demonstrate that GMP-Cor can extend to other biological systems, such as persistent cancer cells, where it separates proliferating from drug-arrested cells[3].

  • Top Cited Papers
    Open Access

    Differentiation between regulated and disrupted growth arrests allows tailoring of effective treatments for antibiotic persistence

    by Adi Rotem, Yoav Kaplan, Orit Gefen, Irine Ronin, Alon Gutfreund, Hagai Rappeport, Raya Faigenbaum-Romm, Nitsan Naor, Elisheva Stav, Oded Agam, et al.

    Antibiotic persistence, typically attributed to dormant bacteria, is known to be a major cause of treatment failure. However, despite many years of intense research, no clear consensus on its mechanism has emerged. Here, we demonstrate that high survival under antibiotics may originate from two fundamentally different growth-arrest archetypes: either from a regulated growth arrest, leading to a protected dormant cellular state, or from a dysregulated disrupted growth arrest. Using modeling and experimental approaches including transcriptomics, microcalorimetry, and microfluidics, we unveil the characteristics and vulnerabilities of each growth-arrest archetype. In particular, disrupted bacteria show a general impairment of membrane homeostasis. This understanding resolves previous conflicting results regarding characteristics of persisters and allows tailoring treatments that target the different growth-arrested bacteria. The fundamental distinction between regulated and disrupted growth arrests should be broadly relevant for the description of cells under stress.